<DOC>
	<DOCNO>NCT00004126</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine paclitaxel oxaliplatin treat patient recurrent advance non-small cell lung cancer .</brief_summary>
	<brief_title>Paclitaxel Oxaliplatin Treating Patients With Recurrent Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine overall , partial , complete response rate patient advance non-small cell lung cancer treat oxaliplatin plus paclitaxel . II . Assess overall survival , time tumor progression , toxicity associate combination regimen patient population . III . Assess neurologic toxicity combination regimen correlation creatinine clearance patient . OUTLINE : This multicenter study . Patients receive paclitaxel IV 1 hour follow oxaliplatin IV 2 hour day 1 . Treatment repeat every 3 week absence disease progression unacceptable toxicity . Patients follow least 2 year death . PROJECTED ACCRUAL : Approximately 17-37 patient accrue study within 24 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung cancer ( NSCLC ) Stage IIIB pleural effusion OR Stage IV OR Recurrent disease Bidimensionally measurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Karnofsky 50100 % Life expectancy : Not specify Hematopoietic : WBC great 3,000/mm3 Absolute neutrophil count least 1,500/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin normal SGOT le 2 time normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 50 mL/min BUN less 1.5 time normal Cardiovascular : No symptomatic congestive heart failure No unstable angina myocardial infarction within past 6 month No evidence heart block great first degree , bundle branch block , ventricular supraventricular arrhythmia Other : No allergy platinum compound antiemetic appropriate study No uncontrolled illness No active ongoing infection No evidence peripheral neuropathy physical exam history Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy advance NSCLC At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : Not specify Other : No concurrent investigational agent No concurrent antiretroviral therapy HIV positive patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>